Cointime

Inimex Pharmaceuticals

company

About

Inimex Pharmaceuticals is a clinical-stage company focused on the development and commercialization of innate defense regulators.

  • 11 - 50

Highlights

Total Funding Amount
$2M $26.50M
Funding Rounds
3
Investors
3

Details

Last Funding Type
Series A
Last Funding Money Raised
$2M
Industries
Biotechnology,Medical,Pharmaceutical
Founded date
Jan 1, 2001
Number Of Employee
11 - 50
Operating Status
Active

Inimex Pharmaceuticals, Inc. is a clinical stage company focused on the development and commercialization of Innate Defense Regulators (IDRs), novel first in class drugs that selectively trigger the body's innate defenses without causing inflammation.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$2M $26.50M
Inimex Pharmaceuticals has raised a total of $2M $26.50M in funding over 2 rounds. Their latest funding was raised on Jun 2, 2008 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 2, 2008 Series B $22M 2 — — Detail
Dec 8, 2004 Series A $2M 2 British Columbia Discovery Fund — Detail
Jul 6, 2004 Series A $4.50M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
1
3
Inimex Pharmaceuticals is funded by 3 investors. British Columbia Discovery Fund and Canadian Medical Discoveries Fund are the most recent investors.
Investor Name Lead Investor Funding Round
British Columbia Discovery Fund Yes Series A
Canadian Medical Discoveries Fund — Series B
BC Advantage Funds — Series B
Cointime
เนื้อหา
บริษัท